FDA

FDA Extends Bristol Diabetes Drug Deadline
TheStreet.com
Fri, 04/24/09 - 06:12 am
FDA
diabetes
Bristol-Myers Squibb
Onglyza
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thu, 04/23/09 - 10:05 am
FDA
drug trials
Acorda Therapeutics
GTx
Alkermes
FDA Calendar Updates: Diabetes
Seeking Alpha
Thu, 04/23/09 - 09:49 am
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Onglyza
alogliptin
Takeda
Novo Nordisk
Victoza
Bristol-Myers, AstraZeneca drug approval delayed
Marketwatch
Thu, 04/23/09 - 08:30 am
Bristol-Myers Squibb
FDA
AstraZeneca
Onglyza
diabetes
Official: FDA to OK Plan B for 17-year-olds
Google/AP
Wed, 04/22/09 - 03:54 pm
FDA
birth control
Plan B contraceptive
Teva Pharmaceuticals
Merck's Transaminases Transgression
CNBC
Wed, 04/22/09 - 07:11 am
Merck
earnings
FDA
migraines
FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
Seeking Alpha
Tue, 04/21/09 - 09:17 am
FDA
drug trials
Merck
Dendreon
Actelion
Forest Labs
Cypress Bioscience
Cell Therapeutics
Should FDA show us the search-ad data?
Fierce Pharma
Tue, 04/21/09 - 08:58 am
FDA
search-ad data
FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics
Seeking Alpha
Tue, 04/21/09 - 07:47 am
FDA
drug trials
Allos
Thoratec
FDA, Clinical Trial Calendar Updates: Discovery, Impax Labs
Seeking Alpha
Tue, 04/21/09 - 06:40 am
Impax Labs
FDA
drug trials
Discovery Labs
Surfaxin
Vion Pharmaceuticals: Onrigin application accepted but barriers remain
Pharmaceutical Business Review
Mon, 04/20/09 - 10:56 am
Vion Pharmaceuticals
Onrigin
FDA
leukemia
More FDA frustration for Discovery Labs
Bizjournals.com
Mon, 04/20/09 - 10:39 am
FDA
Discovery Labs
Surfaxin
Cipla Declines on Report FDA Finds Production Flaws
Bloomberg
Mon, 04/20/09 - 08:36 am
Cipla
India
FDA
Recent FDA Warnings Could Signify A Shift
Investors Business Daily
Sat, 04/18/09 - 11:14 am
FDA
Drugmaker Schering-Plough awaits acquisition by Merck, FDA ruling on psychiatric medicine
Yahoo/AP
Fri, 04/17/09 - 06:15 pm
Merck
earnings
Schering Plough
buyouts
FDA
Saphris
bipolar disorder
schizophrenia
Biogen Idec Receives Approval for TYSABRI High Titer Production
Yahoo
Thu, 04/16/09 - 08:33 am
Biogen Idec
Tysabri
FDA
MS
multiple sclerosis
Botox Rival Faces Delay in FDA Marketing Approval
Bloomberg
Tue, 04/14/09 - 10:07 am
Botox
FDA
Allergan
Medicis
Reloxin
Will These Drugs Get Past the FDA?
Motley Fool
Tue, 04/14/09 - 08:36 am
FDA
PDUFA
Savient
Medicis
Discovery Labs
Schering Plough
JNJ
Novo Nordisk
AstraZeneca
Updated FDA, Clinical Trial Calendars: Myriad Pharma Announces Phase 1 Trial
Seeking Alpha
Fri, 04/10/09 - 09:26 am
FDA
drug trials
Myriad Genetics
Novartis
AstraZeneca
pSivida
Novartis is FDA's first priority review voucher recipient for gaining approval of a tropical disease therapy
InVivo
Thu, 04/9/09 - 09:09 am
FDA
Novartis
malaria
review vouchers
Coartem

Pages